Recent trends in the epidemiology and clinical outcomes of inflammatory bowel disease in South Korea, 2010-2018

Figure 1 CONSORT flow diagram illustrating the study process. IBD: Inflammatory bowel disease; ER: Emergency room.

Figure 2 Incidence of Crohn’s disease and Ulcerative colitis, from 2010 to 2018 in South Korea. A: Crohn’s disease; B: Ulcerative colitis. UC: Ulcerative colitis; CD: Crohn’s disease.

Figure 3 Age-specific incidence of Crohn’s disease and ulcerative colitis in 2010, 2014, and 2018 in South Korea. A: Crohn’s disease; B: Ulcerative colitis.

Figure 4 Age- and sex-specific incidence of Crohn’s disease and ulcerative colitis in 2018. A: Crohn’s disease; B: Ulcerative colitis. UC: Ulcerative colitis; CD: Crohn’s disease.

Figure 5 Temporal trend of medication use in patients with Crohn’s disease and ulcerative colitis, 2010-2018. A: Ulcerative colitis; B: Crohn’s disease. 5-ASA: 5-aminosalicylates.

Figure 6 Temporal trend of clinical outcomes in patients with Crohn’s disease and ulcerative colitis, from 2010 to 2018. A: Ulcerative colitis; B: Crohn’s disease. ER: Emergency room.